search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
57


Figure 3. Selectivity comparison of a single versus triple quadrupole system for fluoxymesterone-M2 at MRPL levels.


groups in order to reduce the polarity of the substance. Underivatised they would possibly stick in the glass vial or liner. The derivatisation step was fully automated using a Thermo Scientific Triplus RSH Autosampler. This enabled batch derivatisation in dedicated preparation cycles (a batch of 6 samples was derivatised prior to injection) or the use of a sequential procedure in which each sample was derivatised and injected. Prior to injection, the samples were transferred into Thermo Scientific Chromacol GOLD-Grade inert glass vials (Type 1 hydrolytic class glass, 29% free silanol groups on the surface) to minimise adsorption to the vial surface. [4]


GC-MS analysis


Following sample preparation, the samples were injected into the GC-MS system. The samples were separated using a Thermo Scientific TRACE 1310 GC system coupled with a Thermo Scientific TSQ 8000 triple quadrupole mass spectrometer. The triple quadrupole MS data were compared to an Q Exactive Orbitrap mass analyser to see, what benefits in resolution Orbitrap can provide. Table 1 shows the GC and GC-MS parameters used.


Results


GC-QqQ offers good selectivity for endogenous and exogenous steroids, as well as other relevant analytes of interest in urine. This technology is widely used and is well established in antidoping laboratories around the world. For the non-targeted


approach, results are shown on a GC- HRAM with 1 ppm mass accuracy across a broad linearity range, including good sensitivity, and linearity for a large number of compounds.


GC-QqQ enables doping control laboratories to perform screening, confirmation, and quantification of analytes in complex matrices in a single analysis without the need to change their current extraction and GC separation methods. The identification and quantitation of anabolic- androgenic steroids (AAS) is well studied using GC-QqQ technology. GC-QqQ offers significant benefits over LC-MS interfaced to atmospheric ionisation sources, which are limited by poor ionisation. Selected reaction monitoring (SRM) provides trace- level detection of the steroids of interest, separating the chemical noise of the matrix from the signal and assuring high sensitivity and selectivity even in very complex matrices, such as camel and horse urine.


GC coupled with single quadrupole MS in selected ion monitoring (SIM) mode has been widely used for anti- doping applications, and it is still used in laboratories for many applications. However, for steroids analysis, single quadrupole systems are limited in terms of selectivity and sensitivity [1].


Figure 3 shows the selectivity of single versus triple quadrupole systems for a real urine sample containing fluoxymesterone-M2. The results highlight that the single quadrupole system did not provide the necessary sensitivity and selectivity. Co-elution’s from the matrix make it difficult to determine the


identity of the analyte and also reduce the sensitivity of the measurement. SRM using the triple quadrupole system, on the other hand, provides both excellent sensitivity and selectivity.


The Rio de Janeiro Doping Control Laboratory (LBCD–LADATEC) analysed approximately 500 samples per day during the 2016 Summer Olympic Games. To meet these demanding sample throughput requirements, robust and reliable analytical workflows were essential. Table 2 shows the World Anti-Doping Agency Minimum Required Performance Levels (WADA/MRPL) and the LOD of banned substances and their metabolites.


Table 2. Limits of detection. Compound


Nandrolone


19-Norandrosterone (19-NA)


19-NE Clenbuterol


WADA MRPL (ng/mL)


5 2


2 0.2


3’-hydroxystanozolol 2 Etilefrine


Norfenefrine Methadone Zilpaterol


Ethylestrenol Oxycodone


Oxymorphone Nandrolone


Mesterolone P


100 100 50 5 5


50 50 5 5


LOD (ng/mL)


2.5 0.4


1


0.1 1


50 50 5 1 1 5


10


2.5 2.5


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68